Is This the Bottom?<br />By Rev Shark<br />RealMoney.com Contributor<br />2/19/2008 8:48 AM EST <br /><br /><br />Socialism is a philosophy of failure, the creed of ignorance, and the gospel of envy, its inherent virtue is the equal sharing of misery. <br />-- Winston Churchill<br /><br />Nationalization of the troubled Northern Rock Bank by the government of the U.K. is helping to spark a rally this morning. The misery of the bank's deposits will now be shared by taxpayers throughout the U.K., and apparently that is a good thing as far as investors are concerned. <br /><br />While the market is celebrating this bailout, the write-offs of bad debt by major firms continue to grow. This morning, Credit Suisse (CS) and Lehman (LEH) are the latest to confess that they still have more losses to declare. The market is still struggling to discount the ultimate cost of the credit crunch, and worries are growing that it is spreading into other areas, such as commercial mortgages. <br /><br />Nonetheless, the market starts the week in somewhat oversold conditions and with so much pessimism in the air that it won't take much news to spark a rally. The overall news flow has some positives, such as the earnings report form Wal-Mart (WMT) and higher metals and oil prices. <br /><br />The big question we have to contemplate at this point is whether the market is finally pricing in the worst and putting in a bottom, or whether this is just another bear-market spike that will quickly dash hopes. <br /><br />There certainly are many folks who are anxious to declare that the market has bottomed and is ready to start a steady upward move. That may indeed be the case, but there is no real proof that the worst is over. Stocks have not shown that they can be trusted at this point, and trusting in some strength to start the week is particularly dangerous. <br /><br />One fascinating thing about the thinking on Wall Street is that many traders shrug off and minimize the losses that occur by buying too early but are overwhelmed with distress should they be a bit late in buying a market in the early stages of recovery. <br /><br />Since traditional Wall Street has a great bias toward averaging down into weakness, traders are very quick to celebrate every time we have a countertrend bounce within a downtrend. The fact that they were buying too early suddenly doesn't feel so bad, and their celebratory mood causes the underinvested on the sidelines to hurry and get some exposure so that they won't be left out of the glorious rally that is now being anticipated. <br /><br />We have a bounce within the downtrend kicking in this morning. Whether it becomes the beginning of the end of the downtrend, we will have to wait and see, but there is no reason to play this as anything other than a short-term bounce. <br />------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: AKNS +5.7%, HOC +5.3%, MSO +4.4%, MHS +3.3%, GIS +2.9%, FOSL +2.8%, SHOO +1.6%, RTI +1.4%, KALU +1.3%, WMT +1.1%... Select European financials trading higher: LYG +9.1%, ING +8.9%, BCS +8.4% (ups write-down to $3.1 bln but reported profits broadly in line with analysts' expectations), HBC +3.5%... Select Chinese names trading higher following Bank of China surging 7.8% (and Heng Seng closing +1.5%) after its chairman said it had set aside enough provisions to cover its exposure to subprime credit: CEO +4.1%, ACH +4.1%, LFC +3.0%, SEED +2.2%, PTR +1.9%, JRJC +1.8%, BIDU +1.5%, CHL +1.3%... Other news: BHP +4.3% and RTP + 4.2% (still checking), QDEL +3.7% (Cramer makes positive comments on MadMoney), ARRS +3.5% (announces a $100 mln stock repurchase program), TOT +3.4% (still checking), FSLR +3.0% (up in sympahty with AKNS), SNY +2.0% (Sanofi-Aventis and UCB announce the FDA approves oral solution for the relief of seasonal and year round allergies and chronic Idiopathic Urticaria)... Analyst upgrades: ENCY +29.4% (upgraded to Buy at Collins Stewart), RIO +5.8% (upgraded to Overweight at Morgan Stanley), GFI +4.8% (upgraded to Overweight at HSBC), HANS +4.7% (upgraded to Overweight at JPMorgan), MU +4.6% (upgraded to Overweight at Thomas Weisel), GSX +4.5% (upgraded to Overweight at JPMorgan), LDK +4.5% (upgraded to Neutral at tier 1 firm), NICE +3.5% (upgraded to Buy at UBS), FBTX +3.3% (upgraded to Mkt Perform at Keefe Bruyette), B +2.9% (upgraded to Buy from Hold at BB&T), X +2.9% (upgraded to Buy at UBS), IAG +2.2% (upgraded to Neutral at HSBC), DROOY +1.7% (upgraded to Neutral at HSBC), UNH +1.3% (upgraded to Outperform at BMO Capital), WYE +1.0% (upgraded to Overweight at Morgan Stanley).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance: ONXX -20.0%, UTHR -5.9%, MPEL -3.8%, CSG -3.5%, GPC -3.2%, ALCO -2.2%, GTXI -1.0%... Other news: TONE -16.7% (CSE announces that it will continue to evaluate its merger transaction with TierOne), ALJ -15.0% (shut its Big Spring, Texas refinery due to an explosion), GIVN -12.9% (receives 'not substantially equivalent' letter from FDA regarding application to market PillCam COLON in U.S.), TMS -9.7% (continued weakness from last weeks decline)... Analyst downgrades: SIGM -3.7% (downgraded to Neutral at Baird), UBS -1.2% (downgraded to Peer Perform at Bear Sterns), FTI -1.0% (downgraded to Neutral at JPMorgan).